Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | ATRAAtara Biotherapeutics, Inc.FY2025 · Dec |
|---|---|
| Revenue | $120.77M |
| Revenue, yoy | −6.3% |
| Net income | $32.69M |
| Net income, yoy | +138.3% |
| Net margin | 27.1% |
| Free cash flow | $50.94M |
| FCF margin | -42.2% |
| EPS, diluted | $2.57 |
Add another company.